Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Novatti - June Quarter FY21 Results Presentation (ASX:NOV)

To view the presentation, download the attached PDF.

Novatti Group - June Quarter FY21 Activities Report and Appendix 4C1 (ASX:NOV)

Highlights New record quarterly sales revenue of more than $4.9m, up 63% year-on-year Payment processing business delivers 9th consecutive quarter of record sales revenue Record ...read more

Next Science - Record revenue growth in 1H 2021 (ASX:NXS)

Next Science Limited (ASX:NXS) (Next Science) today announces its Quarterly Activity Report and Appendix 4C Quarterly Cash Flow Report for the period 1 April 2021 to 30 June 2021 (Q2). Highlights...read more

Next Science - Quarterly Activity Report - 30 June 2021 (ASX:NXS)

Judith Mitchell, Managing Director said: “In the first half of 2021, we delivered our best single half result since IPO. We reported 271% revenue growth (unaudited) on pcp (which was heavily p...read more

Next Science - Appendix 4C - 30 June 2021 (ASX:NXS)

To view the Quarterly cash flow report for entities subject to Listing Rule 4.7B, download the attached PDF.

Novatti Group - Presentation, Capital Raising & Strategic Acquisition (ASX:NOV)

To view the presentation, download the attached PDF.

Novatti Group - Becoming a substantial holder for RKN (ASX:NOV)

To view the Notice of initial substantial holder, download the attached PDF.

Novatti Group - Capital Raising and Strategic Stake Expands Growth Strategy (ASX:NOV)

Highlights -- Expanded growth strategy to launch with $45 million capital raising under a $40 million placement and a $5 million share purchase plan -- Novatti to expand its presence in existing...read more

Novatti Group - Proposed issue of securities (ASX:NOV)

To view the Proposed issue of securities, download the attached PDF.

Proposed issue of securities - NOV (ASX:NOV)

To view the Proposed issue of securities, download the attached PDF.

Novatti Group - Strategic Stake in Reckon Limited and Capital Raising (ASX:NOV)

Novatti Group Limited (ASX:NOV) (Novatti or Company), is pleased to announce that it has entered into share purchase agreements for the acquisition, subject to completion of a capital raising, of an...read more

Novatti - Trading halt (ASX:NOV)

The securities of Novatti Group Limited (‘NOV’) will be placed in trading halt at the request of NOV, pending it releasing an announcement. Unless ASX decides otherwise, the securities w...read more

Nyradas NYX-PCSK9i with Statin Achieves 65% Cholesterol Reduction in Preclinical Study (ASX:NYR)

Nyrada Inc (ASX: NYR) (“Nyrada” or “the Company”) a preclinical stage, drug development company specialising in novel small molecule drugs to treat cardiovascular and neurolo...read more

Next Science - Zimmer complaint (ASX:NXS)

Next Science Limited (ASX:NXS) (Next Science / Company) advises that it has agreed to open negotiations with Zimmer, Inc (Zimmer), a global leader in orthopaedics and hip and knee replacement surger...read more

Nyrada - Improved Drug Candidate Selected for WRAIR Studies (ASX:NYR)

Nyrada Inc (ASX: NYR), a preclinical stage, drug development company specialising in novel small molecule drugs to treat cardiovascular and neurological diseases, today announces the selection of a ...read more

Viewing: 1 - 15 of 200 Previous | Next